Safety, Tolerability, Pharmacokinetic and Microbiological Investigation of GSK3882347 in Female Participants With Urinary Tract Infections

Clinical trial NCT05138822 · COMPLETED

Trial details

NCT number: NCT05138822
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Uncomplicated Urinary Tract Infections Urinary Tract Infections

Start date: 2022-05-18
Primary completion: 2024-12-03
Enrollment: 140

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.